Drug Trial Radar · NCT02029495
Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis
Last checked: Nov 20, 2026Latest source record: May 19, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
478
Actual
Start
Mar 2014
Primary completion
Oct 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 8, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis.
Conditions
- Psoriatic Arthritis
Interventions
210 mg brodalumabDrug
210 mg brodalumab administered via subcutaneous injection
140 mg brodalumabDrug
140 mg brodalumab administered via subcutaneous injection
PlaceboDrug
Placebo administered via subcutaneous injection until week 24.
Primary outcomes
What the sponsor says the trial is designed to measure.
- American College of Rheumatology (ACR) 20 ResponseTime frame: 16 weeks
Locations
152 sites in 17 countries. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama
Research Site
Tuscaloosa, Alabama
Research Site
Peoria, Arizona
Research Site
Scottsdale, Arizona
Research Site
Los Angeles, California
Research Site
Mather, California
Research Site
Murrieta, California
Research Site
Palm Desert, California
Research Site
Tustin, California
Research Site
Upland, California
Research Site
Jupiter, Florida
Research Site
Tamarac, Florida
Research Site
Tampa, Florida
Research Site
Gainesville, Georgia
Research Site
Meridian, Idaho
Research Site
Springfield, Illinois
Research Site
Bowling Green, Kentucky
Research Site
Somerset, Kentucky
Research Site
Frederick, Maryland
Research Site
Wheaton, Maryland
Research Site
Worcester, Massachusetts
Research Site
Lansing, Michigan
Research Site
Eagan, Minnesota
Research Site
Omaha, Nebraska
Research Site
Clifton, New Jersey
Research Site
Great Neck, New York
Research Site
Lake Success, New York
Research Site
New York, New York
Research Site
Plainview, New York
Research Site
Asheville, North Carolina
Research Site
Bend, Oregon
Research Site
Portland, Oregon
Research Site
Duncansville, Pennsylvania
Research Site
Charleston, South Carolina
Research Site
Hixson, Tennessee
Research Site
Austin, Texas
Research Site
Houston, Texas
Research Site
San Antonio, Texas
Research Site
Danville, Virginia
Research Site
Seattle, Washington
Showing 40 of 152 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.